92 related articles for article (PubMed ID: 31092428)
1. Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.
Kim JY; Kim SH; Kim HS
Anticancer Res; 2019 May; 39(5):2361-2367. PubMed ID: 31092428
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.
Kim HS; Yoon G; Do SI; Kim SJ; Kim YW
Oncotarget; 2016 Mar; 7(12):15187-99. PubMed ID: 26942563
[TBL] [Abstract][Full Text] [Related]
3. Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma.
Woo HY; DO SI; Kim SH; Song SY; Kim HS
Anticancer Res; 2019 Oct; 39(10):5361-5367. PubMed ID: 31570430
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC
J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
Jung YY; Sung JY; Kim JY; Kim HS
Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
[TBL] [Abstract][Full Text] [Related]
6. Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis.
Wang P; Cao Y; Zhan D; Wang D; Wang B; Liu Y; Li G; He W; Wang H; Xu L
Int J Med Sci; 2018; 15(13):1480-1485. PubMed ID: 30443169
[No Abstract] [Full Text] [Related]
7. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
8. Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
Sung HY; Han J; Ju W; Ahn JH
Oncol Rep; 2016 Jul; 36(1):535-41. PubMed ID: 27220283
[TBL] [Abstract][Full Text] [Related]
9. The Epigenetic Modifier 5-Aza-2-deoxycytidine Triggers the Expression of
Dudzik P; Trojan SE; Ostrowska B; Zemanek G; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Anticancer Res; 2019 May; 39(5):2395-2403. PubMed ID: 31092432
[TBL] [Abstract][Full Text] [Related]
10. EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.
Rattanapan Y; Korkiatsakul V; Kongruang A; Chareonsirisuthigul T; Rerkamnuaychoke B; Wongkularb A; Wilailak S
Cancer Genet; 2018 Aug; 224-225():37-40. PubMed ID: 29778234
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
[TBL] [Abstract][Full Text] [Related]
12. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
13. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
15. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Qu PP; Shi Z; Li N
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
[TBL] [Abstract][Full Text] [Related]
16. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
18. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma.
Ni H; Zhou Z; Jiang B; Yuan X; Cao X; Huang G; Li Y
Tumour Biol; 2017 Mar; 39(3):1010428317695025. PubMed ID: 28351314
[TBL] [Abstract][Full Text] [Related]
20. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
